プロの翻訳者、企業、ウェブページから自由に利用できる翻訳レポジトリまで。
en respondent var prædefineret til at have en stigning i 4 - ugers- frekvensen af tilfredsstillende aktiviteter på > 1.
in the combined phase iii data, excluding patients taking oral cee, in whom there was no significant improvement in sexual function, 50.7% of women (n=274) treated with intrinsa and 29.4% of those treated with placebo (n=269) were responders with regard to total satisfying sexual activity (primary endpoint), when a responder was predefined as having an increase in the 4-week frequency of satisfying activities of > 1.